Cargando…

Cell fate takes a slug in BRCA1-associated breast cancer

Understanding why BRCA1 mutation carriers have a predilection for developing clinically aggressive basal-like breast tumors could inform the development of targeted treatment or prevention strategies. Analysis of both mouse and human mammary epithelial cells has identified a role for BRCA1 in orches...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindeman, Geoffrey J, Visvader, Jane E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3219185/
https://www.ncbi.nlm.nih.gov/pubmed/21489318
http://dx.doi.org/10.1186/bcr2840